Abortion‑pill Maker Danco Labs Seeks Supreme Court Stay on In‑Person Exam Rule
Fast facts
- Category: Business
- Language: EN
- Published: 2026-05-02 16:33 UTC
- Sources: The Guardian Business
Danco Laboratories, a producer of the abortion medication mifepristone, filed an emergency appeal to the U.S. Supreme Court asking to block a lower‑court ruling that would require patients to have an in‑person exam before receiving the drug by mail. The appeal follows a temporary injunction from the Fifth Circuit that halted the telemedicine prescribing restriction. Danco argues the rule endangers access to care and seeks immediate relief while the case proceeds.